Life ScienceCompany
Eidos Therapeutics Ownership
Who owns Eidos Therapeutics?
Eidos Therapeutics is owned by BridgeBio Pharma. It was acquired on October 5, 2020.
Was Eidos Therapeutics formerly PE-backed?
Yes. Eidos Therapeutics was formerly owned by 1 private investor.
Eidos Therapeutics Business Overview
Where is Eidos Therapeutics headquartered?
Eidos Therapeutics is headquartered in San Francisco, California.
How many employees does Eidos Therapeutics have?
Eidos Therapeutics has 70 employees.
What sector is Eidos Therapeutics in?
Eidos Therapeutics is a life science company.
When was Eidos Therapeutics founded?
Eidos Therapeutics was founded in 2013.
Life Science M&A Summary in 2020
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.
Join Mergr to view all 284 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 261 by strategics.